ChangeNOW CSO Pauline Shangett digs into the infrastructure underpinning the exchange’s simple, streamlined frontend.
Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal fourth ...
Replimune Group, Inc. nears a pivotal FDA AdCom for RP1 ahead of an Aug 2, 2026 decision. Click for this REPLY stock update ...
Arby's Customer Sues Store Manager After Allegedly Contaminated Sandwich Left Her With a Lifelong Viral Infection ...
Pediatric hospital medicine is rapidly advancing with new research focusing on clinical management, quality improvement, health equity, and technology. This summary highlights the top articles from ...
If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...
Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...
Abstract: A recent paper by Chang develops a new algorithm, called the simplex growing algorithm, which has shown promise in endmember extraction. There is an erroneous description made for one of ...
The Ricoh SP-2240N is geared to make short work of digitizing all of your business paperwork with speed, efficiency and the ...
Leader of Opposition Simplex Chithyola Banda has called on government to immediately reverse the newly announced 100 percent increase in public university tuition fees, warning that the decision risks ...
Opposition Leader Simplex Chithyola Banda has delivered a grim assessment of Malawi's economy, telling residents of Bwaila that ordinary families are bearing the full weight of a collapsing currency, ...